U.S. authorities have accused a former Lazard banker, Mr. Kim, of orchestrating an insider-trading scheme that allegedly yielded $41 million. The scheme reportedly involved trading on non-public information related to major healthcare deals between 2020 and 2023. While Kim is no longer with Citi, the complaint details activities from a prior employer. Lazard advised on numerous significant healthcare transactions during the period in question.